Pediatric Clonidine Toxicity: A Review.

Area of Science:

• Pediatric Toxicology
• Pharmacology
• Emergency Medicine

Background:

• Clonidine prescriptions are rising in children for behavioral issues like ADHD.
• This trend leads to increased pediatric exposures and toxic ingestions.
• Young children (<5 years) are most affected, often via unintentional ingestion.

Purpose of the Study:

• To review the toxicokinetics, clinical presentation, and management of pediatric clonidine toxicity.
• To provide clinicians with guidance for diagnosing and treating clonidine overdose in children.
• To highlight the importance of early recognition and intervention.

Main Methods:

• Literature review of toxicokinetics, clinical presentation, and management strategies.
• Analysis of common symptoms and diagnostic approaches.
• Evaluation of treatment options, including supportive care and naloxone.

Main Results:

• Clonidine toxicity presents as an opioid toxidrome with CNS depression, miosis, bradycardia, and hypotension.
• Diagnosis is typically clinical.
• Supportive care is the mainstay of treatment; high-dose naloxone may be needed for severe CNS depression.

Conclusions:

• Clonidine toxicity in children requires prompt recognition and management.
• Supportive care is crucial, and naloxone should be considered for severe symptoms.
• Delayed and prolonged toxicity, especially from transdermal patches, necessitates vigilant monitoring.